Latest news with #Glipizide
Time of India
01-08-2025
- Health
- Time of India
Dieticians back traditional Indian foods for lactating mothers, but with a scientific twist
Nagpur: Clinical dieticians and doctors trained in modern medicine are now advocating the use of traditional Indian postnatal foods like 'gond laddoos', and dry fruits to support lactation, but with necessary modifications rooted in science. Tired of too many ads? go ad free now Speaking during World Breastfeeding Week (August 1–7), the Indian Dietetic Association (IDA), Nagpur Chapter and NetProFan, Nagpur Chapter, jointly emphasised that traditional foods, long trusted by Indian households, can still be effective in boosting milk production if consumed in a modern, balanced form. "Traditional Indian postnatal diets were rich in ghee and sugar, aimed at restoring strength and enhancing lactation. But given current issues like postpartum weight gain, gestational diabetes, and anaemia, we need to update these recipes for today's mothers," said Dr Renuka Mainde, convener of NetProFan, Nagpur Chapter. "Instead of consuming heavy ghee-laden laddoos, we now recommend powdered versions of the same ingredients — like gond, nuts, and seeds — with milk or porridge. This maintains nutritional value without adding health risks," she said. Dr Kavita Bakshi, convener of IDA, Nagpur Chapter, added, "Some mothers struggle to produce enough milk due to poor nutrition. Foods like oats, almonds, flaxseeds, fennel, papaya, and leafy greens — rich in B-vitamins, iron, and healthy fats — are natural galactagogues. But all of this should be part of a balanced diet, and not a replacement for proper medical advice." Dr Kavita Gupta, secretary of IDA, Nagpur Chapter, explained how breastfeeding benefits extend to both mother and child. Tired of too many ads? go ad free now "It improves glucose tolerance, reduces risk of diabetes and breast cancer, and lowers high blood pressure in women with hyperglycemia in pregnancy. The longer the duration, the better the benefit," Gupta said. She also cautioned lactating women with diabetes to consult doctors before taking any medicines. "Insulin remains the safest, but Metformin and Glipizide are also considered safe in breastfeeding as they do not significantly pass into breast milk," Gupta said. Chanchal Sahani, joint secretary, IDA, Nagpur, pointed out the added value of breast milk in building a baby's immunity, brain development, and emotional bonding while being eco-friendly and cost-effective. "Breastfeeding is a skill. Proper latch and positioning not only help the baby feed better but also prevent problems like nipple pain, engorgement, and low supply," said Shalini Kotamkar, Life Member of IDA. BOX DIETICIANS SUGGEST * Gond laddoos should be consumed in powdered form with milk or porridge instead of heavy ghee-rich pieces * Use unsaturated fats from nuts and seeds instead of excess ghee * Include iron-rich leafy vegetables, pulses, and whole grains to combat anaemia * Avoid fried snacks with trans fats that delay postnatal recovery * Balance sugar intake in traditional sweets to prevent postpartum weight gain and blood sugar spikes
Hans India
26-07-2025
- Health
- Hans India
Study links common diabetes drug with cardiovascular risk
New Delhi: A commonly used type 2 diabetes medication in the US -- Glipizide -- may be linked to a higher rate of heart-related conditions, claimed a study. Researchers from Mass General Brigham examined nationwide data from nearly 50,000 patients treated with different sulfonylureas. They found that glipizide was linked to a higher incidence of heart failure, related hospitalisation, and death compared to dipeptidyl peptidase-4 (DPP-4) inhibitors. The findings are published in JAMA Network Open. 'Patients with type 2 diabetes are at heightened risk of adverse cardiovascular incidents such as stroke and cardiac arrest,' said corresponding author Alexander Turchin, Division of Endocrinology at Brigham and Women's Hospital (BWH). 'While sulfonylureas are popular and affordable diabetes medications, there is a lack of long-term clinical data on how they affect cardiac health in comparison to more neutral alternatives like dipeptidyl peptidase 4 inhibitors,' he added. Type 2 diabetes is a common chronic disease whose prevalence continues to grow worldwide. Individuals with Type 2 diabetes have an increased risk of adverse cardiovascular events, including coronary ischemia, stroke, and heart failure. Mitigation of cardiovascular risk is therefore an important aspect of the treatment of diabetes. The study included 48,165 patients with type 2 diabetes and moderate cardiovascular risk who received care at 10 different study sites across the country. The researchers studied the five-year risk of major adverse cardiovascular events in patients treated with different sulfonylureas (glimepiride, glipizide, or glyburide) or DPP4i in addition to metformin, a primary diabetes medication. They found that glipizide was associated with a 13 per cent increase in cardiovascular risk when compared to DPP4i, while glimepiride and glyburide led to relatively smaller and less clear effects, respectively. 'Our study underscores the importance of evaluating each drug in a particular pharmacological class on its own merits,' said Turchin. The team also called for further research to uncover the underlying mechanisms.
